Gabapentin Capsule
Product Images NDC 68071-2876

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68071-2876). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2876 9)

This is a description of a medication called Gabapentin 300mg contained in a bottle with Lot: 00000 and NDC number: 68071-2876-09. The bottle contains 90 capsules that are oblong, yellow with an opaque body and cap, and each capsule is imprinted with 'AHD' on the cap and 300-ZRD on the body. The medication should be stored at a controlled temperature of 68-77°F and kept out of reach of children. In case of side effects, patients should contact their doctor or the FDA.*

FDA Label Image

Formula (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)

This appears to be a formula for calculating creatinine clearance (ClCr) in patients, which is a measure of kidney function. It takes into account the patient's age, weight, and serum creatinine levels. The formula includes a correction factor for female patients.*

FDA Label Image

Figure1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)

FDA Label Image

Image 1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)

FDA Label Image

Image 2 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)

This appears to be a table showing the pain scores for a 4-week fixed dose period study with two different doses of Gabapentin and a placebo. There are seven time points labeled as Baseline, 1 through 7. There is not enough information to provide further details or context.*

FDA Label Image

Image 3 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)

The text is describing the proportion of responders (patients with a reduction in pain score) in controlled PHN studies. It includes figures for two studies (study 1 and study 2) and information on the cost of GBP 3600 for the study drug, GBP 1800 for a placebo, and GBP 2400 for an unspecified option. There are also some statistical symbols, but the meaning is unclear without further context.*

FDA Label Image

Image 4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.